• Route

  • Cluster question

  • Organisation

Research initiatives

RGM.20.010 – Beta cell replacement therapy for type 1 diabetes

Route: Regenerative medicine: game changer moving to broad areas of application

cluster question: 100 How can we use cells, stem cells, and biomaterials to engineer and regenerate tissues and organs?

Type 1 diabetes is a lifelong autoimmune disease which specifically destroys the insulin producing beta-cells residing in the pancreatic islets […]

View the initiative

RGM.20.011 – Modeling the dietary impact on health with engineered human liver microtissues

Route: Regenerative medicine: game changer moving to broad areas of application

cluster question: 101 Can we model the human body and use smart technologies for health, nutritional, and toxicity research, drastically reducing the use of laboratory animals at the same time?

Better model system are urgently needed to study the impact of diet, nutrients and toxins on human health. This is […]

View the initiative

RGM.20.004 – DIABULC (Diabetic Ulcera: Novel Integrated Therapy and Monitoring)

Route: Regenerative medicine: game changer moving to broad areas of application

cluster question: 100 How can we use cells, stem cells, and biomaterials to engineer and regenerate tissues and organs?

Approach: patient-motivated/driven multidisciplinary consortium that combine patient demands and input with experimental clinical therapy, state-of-the art antimicrobial peptides, clinical application […]

View the initiative